Positron CEO and president RobertM. Guezuraga has left the company, the Houston-based developerof PET scanners announced this month. Gary B. Wood, the vendor'schairman, will assume Guezuraga's responsibilities on an interimbasis until a new CEO is found.
Positron CEO and president RobertM. Guezuraga has left the company, the Houston-based developerof PET scanners announced this month. Gary B. Wood, the vendor'schairman, will assume Guezuraga's responsibilities on an interimbasis until a new CEO is found.
Guezuraga had been a member of Positron's board of directorssince 1989 and its chief executive since 1990. He will continueto serve on Positron's board, the company said.
Positron has begun a search for a new chief executive and islooking for an individual with experience in marketing and acquisitions,according to the company.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.